BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31484658)

  • 1. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.
    Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
    Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer.
    Sozio F; Schioppa T; Laffranchi M; Salvi V; Tamassia N; Bianchetto-Aguilera FM; Tiberio L; Bonecchi R; Bosisio D; Parmentier M; Bottazzi B; Leone R; Russo E; Bernardini G; Garofalo S; Limatola C; Gismondi A; Sciumè G; Mantovani A; Del Prete A; Sozzani S
    Cancer Immunol Res; 2023 Sep; 11(9):1280-1295. PubMed ID: 37343073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.
    Monnier J; Lewén S; O'Hara E; Huang K; Tu H; Butcher EC; Zabel BA
    J Immunol; 2012 Jul; 189(2):956-67. PubMed ID: 22696441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine (C-C Motif) Receptor-Like 2 is not essential for lung injury, lung inflammation, or airway hyperresponsiveness induced by acute exposure to ozone.
    Malik F; Cromar KR; Atkins CL; Price RE; Jackson WT; Siddiqui SR; Spencer CY; Mitchell NC; Haque IU; Johnston RA
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29242308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring CCRL2 chemerin binding using accelerated molecular dynamics.
    Bufano M; Laffranchi M; Sozzani S; Raimondo D; Silvestri R; Coluccia A
    Proteins; 2022 Sep; 90(9):1714-1720. PubMed ID: 35437825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis for CCRL2 Regulation of Leukocyte Migration.
    Schioppa T; Sozio F; Barbazza I; Scutera S; Bosisio D; Sozzani S; Del Prete A
    Front Cell Dev Biol; 2020; 8():615031. PubMed ID: 33363177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
    Yoshimura T; Oppenheim JJ
    Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCRL2 promotes antitumor T-cell immunity via amplifying TLR4-mediated immunostimulatory macrophage activation.
    Yin W; Li Y; Song Y; Zhang J; Wu C; Chen Y; Miao Y; Lin C; Lin Y; Yan D; Chen J; He R
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage.
    Del Prete A; Martínez-Muñoz L; Mazzon C; Toffali L; Sozio F; Za L; Bosisio D; Gazzurelli L; Salvi V; Tiberio L; Liberati C; Scanziani E; Vecchi A; Laudanna C; Mellado M; Mantovani A; Sozzani S
    Blood; 2017 Sep; 130(10):1223-1234. PubMed ID: 28743719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men.
    Zimny S; Pohl R; Rein-Fischboeck L; Haberl EM; Krautbauer S; Weiss TS; Buechler C
    Exp Mol Pathol; 2017 Aug; 103(1):1-8. PubMed ID: 28600126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis.
    Zabel BA; Nakae S; Zúñiga L; Kim JY; Ohyama T; Alt C; Pan J; Suto H; Soler D; Allen SJ; Handel TM; Song CH; Galli SJ; Butcher EC
    J Exp Med; 2008 Sep; 205(10):2207-20. PubMed ID: 18794339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies with neutralizing antibodies suggest CXCL8-mediated neutrophil activation is independent of C-C motif chemokine receptor-like 2 (CCRL2) ligand binding function.
    Su Z; Brooks J; Pelker J; Andreyeva T; Sobon H; Gifford R; Powers M; Wang J; Dower C; Hegen M; Messing D; Sheehan AD; Brennan JJ
    PLoS One; 2023; 18(1):e0280590. PubMed ID: 36662882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonredundant role of CCRL2 in lung dendritic cell trafficking.
    Otero K; Vecchi A; Hirsch E; Kearley J; Vermi W; Del Prete A; Gonzalvo-Feo S; Garlanda C; Azzolino O; Salogni L; Lloyd CM; Facchetti F; Mantovani A; Sozzani S
    Blood; 2010 Oct; 116(16):2942-9. PubMed ID: 20606167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.
    Sarmadi P; Tunali G; Esendagli-Yilmaz G; Yilmaz KB; Esendagli G
    Mol Immunol; 2015 Dec; 68(2 Pt C):692-8. PubMed ID: 26563945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCRL2, a fringe member of the atypical chemoattractant receptor family.
    Del Prete A; Bonecchi R; Vecchi A; Mantovani A; Sozzani S
    Eur J Immunol; 2013 Jun; 43(6):1418-22. PubMed ID: 23580473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses
    Regan-Komito D; Valaris S; Kapellos TS; Recio C; Taylor L; Greaves DR; Iqbal AJ
    Front Immunol; 2017; 8():1621. PubMed ID: 29209334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer.
    Kreisel D; Gelman AE; Higashikubo R; Lin X; Vikis HG; White JM; Toth KA; Deshpande C; Carreno BM; You M; Taffner SM; Yokoyama WM; Bui JD; Schreiber RD; Krupnick AS
    Cancer Res; 2012 Sep; 72(17):4311-7. PubMed ID: 22751136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.
    Luangsay S; Wittamer V; Bondue B; De Henau O; Rouger L; Brait M; Franssen JD; de Nadai P; Huaux F; Parmentier M
    J Immunol; 2009 Nov; 183(10):6489-99. PubMed ID: 19841182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
    Wang LP; Cao J; Zhang J; Wang BY; Hu XC; Shao ZM; Wang ZH; Ou ZL
    Med Oncol; 2015 Nov; 32(11):254. PubMed ID: 26487662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma.
    Yin F; Xu Z; Wang Z; Yao H; Shen Z; Yu F; Tang Y; Fu D; Lin S; Lu G; Kung HF; Poon WS; Huang Y; Lin MC
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):168-72. PubMed ID: 23142225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.